16329 studies found for:    "Vascular Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
"Vascular Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)
Conditions: Migraine Disorders;   Heart Disease;   Cerebrovascular Accident;   TIA (Transient Ischemic Attack);   Vascular Diseases;   Peripheral Vascular Diseases
Interventions: Drug: Telcagepant;   Drug: Acetaminophen/Paracetamol;   Drug: Placebo to Telcagepant;   Drug: Placebo to Acetaminophen/Paracetamol
2 Completed Efficacy of Patient Centred Information for Vascular Disease
Condition: Vascular Disease
Interventions: Other: Verbal and written information;   Other: Verbal and electronic information
3 Completed Center for the Study of Vascular Disease in Hispanic and Native Americans
Condition: Vascular Disease
Intervention:
4 Completed Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease
Conditions: Vascular Disease;   Vascular Disease Risk
Intervention:
5 Active, not recruiting Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling
Conditions: Vasculopathy;   Allograft
Intervention: Procedure: Dobutamine stress echocardiography, coronarography, brachial arterial echography
6 Unknown  Testosterone for Peripheral Vascular Disease
Conditions: Hypogonadism;   Peripheral Vascular Disease;   Type 2 Diabetes
Interventions: Drug: Testosterone;   Drug: 0.9% saline
7 Completed Stem Cell Injection for Peripheral Vascular Disease
Condition: Peripheral Vascular Disease
Intervention: Biological: Stem Cell Transplantation
8 Completed Screening DIVA - Diffuse Vascular Disease
Condition: Peripheral Vascular Diseases
Intervention:
9 Completed Testosterone Replacement in Diabetes With Vascular Disease (Version 2)
Conditions: Diabetes Mellitus;   Peripheral Vascular Disease
Interventions: Drug: Testosterone;   Drug: 0.9% saline
10 Completed Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease
Conditions: Hemodialysis Patients;   Peripheral Vascular Disease
Intervention: Drug: Cilostazol
11 Completed Effect of Diet on Vascular Disease in Pre-Menopausal Women
Conditions: Cardiovascular Diseases;   Vascular Disease;   Inflammation;   Insulin;   Triglycerides
Intervention:
12 Active, not recruiting Noninvasive Predictors of Transplant Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention:
13 Active, not recruiting Noninvasive Evaluation of Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention:
14 Unknown  Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: Intravitreal Bevacizumab
15 Completed
Has Results
Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: ranibizumab 0.5 or 0.3 mg/0.05 cc
16 Unknown  Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: ranibizumab 2.0mg
17 Active, not recruiting Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: ranibizumab 0.5 or 2.0 mg/0.05 cc
18 Unknown  Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant
Conditions: Cardiac Allograft Vasculopathy;   Heart Transplant Recipients
Intervention:
19 Completed Response to Ranibizumab in Polypoidal Choroidal Vasculopathy (PCV)and SNPs
Condition: Polypoidal Choroidal Vasculopathy
Intervention:
20 Suspended Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients
Condition: Cardiac Allograft Vasculopathy
Intervention: Drug: Sirolimus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years